[Acral erythema after allogeneic graft of the bone marrow].
Acral erythema (AE) is a painful, erythematous bullous eruption of the palms and soles which is chemotherapy-induced. To the numerous chemotherapies which induce AE we must add, perhaps, a new drug, Vépéside. AE is followed by graft-versus-host-disease in all patients receiving bone marrow transplantation. AE and early GVH disease being very similar, we discuss the differential diagnosis which can be very difficult.
Dechaufour
F
F
Service de Dermatologie, CHRU, Caen.
Dompmartin
A
A
Troussard
X
X
Galateau
F
F
Pedailles
S
S
Remond
B
B
Leporrier
M
M
Leroy
D
D
D000169:Acrodermatitis / Q000209:etiology* / Q000473:pathology; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003561:Cytarabine / Q000009:adverse effects; D004890:Erythema / Q000139:chemically induced* / Q000473:pathology; D005047:Etoposide / Q000009:adverse effects; D005260:Female; D006087:Graft vs Host Reaction; D006801:Humans; D008297:Male; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D003561:Cytarabine; D005047:Etoposide
Erythème acral après greffe de moelle osseuse allogénique.